Jerzy Szaflarski, M.D., Ph.D., has been selected to be a fellow of the American Epilepsy Society.

Published in Faculty Excellence
UAB neurologists have reported the first case study of a patient with a brain bleed linked to consumption of an energy drink.
Published in Focus on Patient Care
The power and promise of personalized medicine: a genetic test can reduce cardiovascular risk for some heart patients
A UAB study will test whether training to modify care-resistant behavior can improve quality of life for family caregivers of dementia patients.
UAB and Auburn will team up for a study of magnetic resonance imaging techniques that could enhance epilepsy surgery.
UAB investigators have won a prestigious White House BRAIN Initiative grant to study the potential benefits of new technology coupled with newly discovered biomarkers in deep brain stimulation for Parkinson’s disease.

UAB and partners launch the PREVeNT study, aimed at preventing the onset of seizures in children with tuberous sclerosis.

After major investments in information technology infrastructure — bringing the fastest supercomputer in Alabama to campus — UAB can now execute tasks in a couple of hours that took an entire day just a year ago. 

Computing challenges are found across the UAB campus, from physics and neurology to genetics and the microbiome. Alabama’s most advanced supercomputer is now at UAB, making it possible to solve these challenges. 

A UAB study sheds light on and suggests a target for treatment of a variant of Guillain-Barré syndrome.

An NIH grant will help support personalized medicine and patient-oriented research at UAB.
Published in Faculty Excellence
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
UAB joins with leading Parkinson’s disease organizations for a Birmingham conference.
Published in Service to Community
Preliminary results from UAB’s CBD oil studies show benefit in seizure control in some patients.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
Alabama ALS chapter honors UAB’s Peter King with Spirit of Lou Gehrig Award.
Published in Faculty Excellence
More evidence that generic medications are as effective as brand name drugs.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
Page 1 of 6
Back to Top